Role of vitamin D-binding protein in isocyanate-induced occupational asthma

Sung Ho Kim, Gil Soon Choi, Young Hee Nam, Joo Hee Kim, Gyu Young Hur, Seung Hyun Kim, Sang Myun Park, Hae Sim Park

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome. Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA. In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA. Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study. The baseline serum VDBP level was significantly higher in group I compared with groups II and III. The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69% and 81%, respectively. The group I subjects with high VDBP (≥ 311 μg/ml) had significantly lower PC20 methacholine levels than did subjects with low VDBP. The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex. Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)2 D3] production. The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate. The TDI-induced VEGF production/ secretion was reversed by 1,25(OH)2 D3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.

Original languageEnglish
Pages (from-to)319-329
Number of pages11
JournalExperimental and Molecular Medicine
Volume44
Issue number5
DOIs
Publication statusPublished - 2012 May 31

Fingerprint

Vitamin D-Binding Protein
Occupational Asthma
Isocyanates
Toluene 2,4-Diisocyanate
Vascular Endothelial Growth Factor A
Blood Proteins
Low Density Lipoprotein Receptor-Related Protein-2
Occupational Groups
Control Groups
Methacholine Chloride
Calcitriol
Proteomics
Early Diagnosis
Screening
Down-Regulation
Epithelial Cells
Phenotype

Keywords

  • Asthma
  • Biological markers
  • Isocyanates
  • Low density lipoprotein receptor-related protein-2
  • Occupational
  • Vascular endothelial growth factora
  • Vitamin D-binding protein

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Role of vitamin D-binding protein in isocyanate-induced occupational asthma. / Kim, Sung Ho; Choi, Gil Soon; Nam, Young Hee; Kim, Joo Hee; Hur, Gyu Young; Kim, Seung Hyun; Park, Sang Myun; Park, Hae Sim.

In: Experimental and Molecular Medicine, Vol. 44, No. 5, 31.05.2012, p. 319-329.

Research output: Contribution to journalArticle

Kim, SH, Choi, GS, Nam, YH, Kim, JH, Hur, GY, Kim, SH, Park, SM & Park, HS 2012, 'Role of vitamin D-binding protein in isocyanate-induced occupational asthma', Experimental and Molecular Medicine, vol. 44, no. 5, pp. 319-329. https://doi.org/10.3858/emm.2012.44.5.036
Kim, Sung Ho ; Choi, Gil Soon ; Nam, Young Hee ; Kim, Joo Hee ; Hur, Gyu Young ; Kim, Seung Hyun ; Park, Sang Myun ; Park, Hae Sim. / Role of vitamin D-binding protein in isocyanate-induced occupational asthma. In: Experimental and Molecular Medicine. 2012 ; Vol. 44, No. 5. pp. 319-329.
@article{d92372bc35ab4899b456929ff8d6f2f2,
title = "Role of vitamin D-binding protein in isocyanate-induced occupational asthma",
abstract = "The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome. Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA. In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA. Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study. The baseline serum VDBP level was significantly higher in group I compared with groups II and III. The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69{\%} and 81{\%}, respectively. The group I subjects with high VDBP (≥ 311 μg/ml) had significantly lower PC20 methacholine levels than did subjects with low VDBP. The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex. Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)2 D3] production. The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate. The TDI-induced VEGF production/ secretion was reversed by 1,25(OH)2 D3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.",
keywords = "Asthma, Biological markers, Isocyanates, Low density lipoprotein receptor-related protein-2, Occupational, Vascular endothelial growth factora, Vitamin D-binding protein",
author = "Kim, {Sung Ho} and Choi, {Gil Soon} and Nam, {Young Hee} and Kim, {Joo Hee} and Hur, {Gyu Young} and Kim, {Seung Hyun} and Park, {Sang Myun} and Park, {Hae Sim}",
year = "2012",
month = "5",
day = "31",
doi = "10.3858/emm.2012.44.5.036",
language = "English",
volume = "44",
pages = "319--329",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "5",

}

TY - JOUR

T1 - Role of vitamin D-binding protein in isocyanate-induced occupational asthma

AU - Kim, Sung Ho

AU - Choi, Gil Soon

AU - Nam, Young Hee

AU - Kim, Joo Hee

AU - Hur, Gyu Young

AU - Kim, Seung Hyun

AU - Park, Sang Myun

AU - Park, Hae Sim

PY - 2012/5/31

Y1 - 2012/5/31

N2 - The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome. Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA. In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA. Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study. The baseline serum VDBP level was significantly higher in group I compared with groups II and III. The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69% and 81%, respectively. The group I subjects with high VDBP (≥ 311 μg/ml) had significantly lower PC20 methacholine levels than did subjects with low VDBP. The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex. Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)2 D3] production. The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate. The TDI-induced VEGF production/ secretion was reversed by 1,25(OH)2 D3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.

AB - The development of a serological marker for early diagnosis of isocyanate-induced occupational asthma (isocyanate-OA) may improve clinical outcome. Our previous proteomic study found that expression of vitamin D-binding protein (VDBP) was upregulated in the patients with isocyanate-OA. In the present study, we evaluated the clinical relevance of VDBP as a serological marker in screening for isocyanate-OA among exposed workers and its role in the pathogenesis of isocyanate-OA. Three study groups including 61 patients with isocyanate-OA (group I), 180 asymptomatic exposed controls (AECs, group II), 58 unexposed healthy controls (NCs, group III) were enrolled in this study. The baseline serum VDBP level was significantly higher in group I compared with groups II and III. The sensitivity and specificity for predicting the phenotype of isocyanate-OA with VDBP were 69% and 81%, respectively. The group I subjects with high VDBP (≥ 311 μg/ml) had significantly lower PC20 methacholine levels than did subjects with low VDBP. The in vitro studies showed that TDI suppressed the uptake of VDBP into RLE-6TN cells, which was mediated by the downregulation of megalin, an endocytic receptor of the 25-hydroxycholecalciferol-VDBP complex. Furthermore, toluene diisocyanate (TDI) increased VEGF production and secretion from this epithelial cells by suppression of 1,25-dihydroxycholecalciferol [1,25(OH)2 D3] production. The findings of this study suggest that the serum VDBP level may be used as a serological marker for the detection of isocyanate-OA among workers exposed to isocyanate. The TDI-induced VEGF production/ secretion was reversed by 1,25(OH)2 D3 treatment, which may provide a potential therapeutic strategy for patients with isocyanate-OA.

KW - Asthma

KW - Biological markers

KW - Isocyanates

KW - Low density lipoprotein receptor-related protein-2

KW - Occupational

KW - Vascular endothelial growth factora

KW - Vitamin D-binding protein

UR - http://www.scopus.com/inward/record.url?scp=84861632055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861632055&partnerID=8YFLogxK

U2 - 10.3858/emm.2012.44.5.036

DO - 10.3858/emm.2012.44.5.036

M3 - Article

C2 - 22314196

AN - SCOPUS:84861632055

VL - 44

SP - 319

EP - 329

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 5

ER -